Zogenix (Zogenix) Change In Inventory : $-3.47 Mil (TTM As of Dec. 2021)

View and export this data going back to 2010. Start your Free Trial

What is Zogenix Change In Inventory?

Zogenix's change in inventory for the quarter that ended in Dec. 2021 was $-2.03 Mil. It means Zogenix's inventory increased by $2.03 Mil from Sep. 2021 to Dec. 2021 .

Zogenix's change in inventory for the fiscal year that ended in Dec. 2021 was $-3.47 Mil. It means Zogenix's inventory increased by $3.47 Mil from Dec. 2020 to Dec. 2021 .

Zogenix's Total Inventories for the quarter that ended in Dec. 2021 was $5.49 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Zogenix's Days Inventory for the quarter that ended in Dec. 2021 was 249.91.

Inventory Turnover measures how fast the company turns over its inventory within a year. Zogenix's Inventory Turnover for the quarter that ended in Dec. 2021 was 0.37.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Zogenix's Inventory-to-Revenue for the quarter that ended in Dec. 2021 was 0.17.

Zogenix Change In Inventory Historical Data

The historical data trend for Zogenix's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zogenix Change In Inventory Chart

Zogenix Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Change In Inventory

Get a 7-Day Free Trial

2.58

-1.03

-3.47

Zogenix Quarterly Data
	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
Change In Inventory	Get a 7-Day Free Trial															-0.02	-1.30	-0.60	0.45	-2.03

Zogenix Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.47 Mil.

Zogenix (NAS:ZGNX) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Zogenix's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	4.497	/	1.642	*	365 / 4
	=	249.91

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Zogenix's Inventory Turnover for the quarter that ended in Dec. 2021 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1.642	/	4.497
	=	0.37

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Zogenix's Inventory to Revenue for the quarter that ended in Dec. 2021 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	4.497	/	26.608
	=	0.17

Zogenix Change In Inventory Related Terms

Thank you for viewing the detailed overview of Zogenix's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Zogenix (Zogenix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zogenix Inc (NAS:ZGNX) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

5959 Horton Street, Suite 500, Emeryville, CA, USA, 94608

Website

https://www.zogenix.com

Zogenix Inc is engaged in developing and commercializing therapeutic solutions for people living with serious and life-threatening rare CNS disorders and medical conditions. Its product candidate includes ZX008, low-dose fenfluramine for the treatment of Dravet syndrome, LGS, and potentially other rare and catastrophic epilepsy disorders.

Executives

Erle T Mast	director	C/O SPIROS DEVELOPMENT CORP II INC, 7475 LUSK BLVD, SAN DIEGO CA 92121
Renee P Tannenbaum	director	9220 KIRBY DRIVE, SUITE 500, HOUSTON TX 77054
Cam L Garner	director	PO BOX 675866, RANCHO SANTE FE CA 92067
Caroline M Loewy	director	300 ELLIOTT AVE WEST, SUITE 500, SEATTLE WA 98119-4114
Denelle J Waynick	director	C/O MYOKARDIA, INC. 1000 SIERRA POINT PARKWAY BRISBANE CA 94005
Mary E. Stutts	director	C/O ZOGENIX, INC. 5959 HORTON STREET EMERYVILLE CA 94608
Ashish M Sagrolikar	officer: EVP & CHIEF COMMERCIAL OFFICER	C/O ZOGENIX, INC. 5858 HORTON STREET, #455 EMERYVILLE CA 94608
Gail M Farfel	officer: EVP/Chief Development Officer	142 TEMPLE STREET, SUITE 205, NEW HAVEN CT 06510
Bradley S. Galer	officer: EVP/Chief Medical Officer	C/O ZOGENIX, INC. 12400 HIGH BLUFF DR., SUITE 650 SAN DIEGO CA 92130
Stephen J Farr	director, officer: President and CEO	[email protected] EMERYVILLE CA 94608
Mark C Wiggins	director	12671 HIGH BLUFF DRIVE SUITE 200, SAN DIEGO CA 92130
Louis C Bock	director	C/O BANKAMERICA VENTURES, 950 TOWER LANE STE 700, FOSTER CITY CA 94404
James B Breitmeyer	director
Shawnte Mitchell	officer: EVP, GC and Secretary	5959 HORTON STREET, SUITE 500, EMERYVILLE CA 94608
Michael P Smith	officer: EVP, CFO, Treasurer & Sec.	887 GREAT NORTHERN WAY VANCOUVER A1 V5T 4T5